Home Global News German scientists say rare COVID-19 blood clots attach to cold viruses –...

German scientists say rare COVID-19 blood clots attach to cold viruses – National


According to German researchers, based on laboratory research, they believe they have found a rare but serious cause blood clotting Events among some people who have received Covid-19 Vaccines made by AstraZeneca Plc and Johnson & Johnson.

Researchers, in a study not yet reviewed by experts, said Wednesday that COVID-19 vaccines used by adenovirus carriers – cold viruses used to transmit vaccine materials – carry some of their cargo into the cell nucleus. Where some instructions for making coronavirus proteins may be misread. They suggest that the resulting proteins could potentially cause blood clotting disorders in a small number of recipients.

Read more:

The number of blood clots associated with the COVID-19 vaccine may be up to 1 in 55,000 blood clots: NACI

Scientists and drug regulators in the United States and Europe are searching for an explanation for the cause of rare but potentially fatal clots with low platelet counts that have led some countries to stop or limit the use of the AstraZeneca and J&J vaccines. Other scientists have proposed competitive theories for clotting conditions.

The continuation of the story is below the ads

“As we work with medical professionals and global health officials, we support the continued investigation and analysis of this rare event. We are sharing them. “AstraZeneca declined to comment.

Click to play movie:

A woman suffers from a rare blood clot disorder following the AstraZeneca vaccine

BC woman suffers from rare blood clot disorder following AstraZeneca vaccine – May 6, 2021

Researchers at Goethe University Frankfurt and other sites explained in their paper that vaccines use a different technology known as messenger RNA (mRNA), such as those developed by BioNTech SE in partnership with Pfizer Inc. and Moderna Inc. , Provide genetic material The corona virus only increases the virus to the fluids in the cells and not to the nucleus of the cells. “All mRNA-based vaccines must show immune products,” the article said.

Read more:

Risks of blood clotting: Comparison of COVID-19 vaccines with common drugs, travel and smoking

This article suggests that vaccine manufacturers using adenovirus vectors can modify the spike protein sequence “to prevent adverse reactions in the joints and to increase the safety of these medicinal products.”


Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.

For latest entertainment news| health news| political news| sports news| travel news| Covid-19 news| Tech news| Digital Marketing| Lyrics


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.